Literature DB >> 1895380

Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.

M Sumner-Smith1, S Roy, R Barnett, L S Reid, R Kuperman, U Delling, N Sonenberg.   

Abstract

The human immunodeficiency virus type 1 Tat protein binds to an RNA stem-loop structure called TAR which is present at the 5' end of all human immunodeficiency virus type 1 transcripts. This binding is centered on a bulge within the stem of TAR and is an essential step in the trans-activation process which results in a dramatic increase in viral gene expression. By analysis of a series of TAR derivatives produced by transcription or direct chemical synthesis, we determined the structural and chemical requirements for Tat binding. Tat binds well to structures which have a bulge of two to at least five unpaired bases bounded on both sides by a double-stranded RNA stem. This apparent flexibility in bulge size is in contrast to an absolute requirement for an unpaired uridine (U) in the 5'-most position of the bulge (+23). Substitution of the U with either natural bases or chemical analogs demonstrated that the imido group at the N-3 position and, possibly, the carbonyl group at the C-4 position of U are critical for Tat binding. Cytosine (C), which differs from U at only these positions, is not an acceptable substitute. Furthermore, methylation at N-3 abolishes binding. While methylation of U at the C-5 position has little effect on binding, fluorination reduces it, possibly because of its effects on relative tautomer stability at the N-3 and C-4 positions. Thus, we have identified key moieties in the U residue that are of importance for the binding of Tat to TAR RNA. We hypothesize that the invariant U is involved in hydrogen bond interactions with either another part of TAR or the TAR-binding domain in Tat.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895380      PMCID: PMC248997     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Tat and Rev: positive regulators of HIV gene expression.

Authors:  C A Rosen; G N Pavlakis
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

2.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

Authors:  K M Weeks; C Ampe; S C Schultz; T A Steitz; D M Crothers
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

3.  Predicting optimal and suboptimal secondary structure for RNA.

Authors:  J A Jaeger; D H Turner; M Zuker
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Bulge loops used to measure the helical twist of RNA in solution.

Authors:  R S Tang; D E Draper
Journal:  Biochemistry       Date:  1990-06-05       Impact factor: 3.162

5.  Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence.

Authors:  S Roy; N T Parkin; C Rosen; J Itovitch; N Sonenberg
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  HIV-1 tat trans-activation requires the loop sequence within tar.

Authors:  S Feng; E C Holland
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

Review 7.  Fluorinated pyrimidines.

Authors:  C Heidelberger
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1965

8.  A covalent adduct between the uracil ring and the active site of an aminoacyl tRNA synthetase.

Authors:  R M Starzyk; S W Koontz; P Schimmel
Journal:  Nature       Date:  1982-07-08       Impact factor: 49.962

9.  Phy M: an RNase activity specific for U and A residues useful in RNA sequence analysis.

Authors:  H Donis-Keller
Journal:  Nucleic Acids Res       Date:  1980-07-25       Impact factor: 16.971

10.  Aminoacyl-tRNA synthetase-catalyzed cleavage of the glycosidic bond of 5-halogenated uridines.

Authors:  S W Koontz; P R Schimmel
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

View more
  30 in total

Review 1.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

2.  An adenosine at position 27 in the human immunodeficiency virus type 1 trans-activation response element is not critical for transcriptional or translational activation by Tat.

Authors:  A D Blanchard; R Powell; M Braddock; A J Kingsman; S M Kingsman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator.

Authors:  E P Loret; P Georgel; W C Johnson; P S Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

4.  Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative.

Authors:  Sara Richter; Cristina Parolin; Barbara Gatto; Claudia Del Vecchio; Egidio Brocca-Cofano; Arnaldo Fravolini; Giorgio Palù; Manlio Palumbo
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

5.  Evidence for a base triple in the free HIV-1 TAR RNA.

Authors:  Hendrik Huthoff; Frederic Girard; Sybren S Wijmenga; Ben Berkhout
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

6.  Interactions of protein side chains with RNA defined with REDOR solid state NMR.

Authors:  Wei Huang; Gabriele Varani; Gary P Drobny
Journal:  J Biomol NMR       Date:  2011-09-25       Impact factor: 2.835

7.  iRED analysis of TAR RNA reveals motional coupling, long-range correlations, and a dynamical hinge.

Authors:  Catherine Musselman; Hashim M Al-Hashimi; Ioan Andricioaei
Journal:  Biophys J       Date:  2007-04-20       Impact factor: 4.033

8.  A 1.3-A resolution crystal structure of the HIV-1 trans-activation response region RNA stem reveals a metal ion-dependent bulge conformation.

Authors:  J A Ippolito; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation.

Authors:  P R Bohjanen; Y Liu; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

10.  A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.

Authors:  P R Bohjanen; R A Colvin; M Puttaraju; M D Been; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.